Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare BATS:HELX BATS:IVRA NYSEARCA:JCHI NYSEARCA:PSIL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHELXFranklin Genomic Advancements ETF$29.16+7.4%$27.72$23.74▼$33.93$11.02M1.053,767 shs2,058 shsIVRAInvesco Real Assets ESG ETF$16.26+1.2%$16.26$14.23▼$18.39$12.42M0.936,019 shs5,386 shsJCHIJPMorgan Active China ETF$52.47-1.8%$49.92$38.75▼$57.19$14.69M0.331,232 shs973 shsPSILAdvisorShares Psychedelics ETF$16.20-1.0%$15.29$7.14▼$17.41$12.96M0.9312,066 shs9,477 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHELXFranklin Genomic Advancements ETF+2.01%+5.71%+3.97%+12.66%-10.07%IVRAInvesco Real Assets ESG ETF+1.06%+1.06%-0.06%+1.88%+6.94%JCHIJPMorgan Active China ETF+2.38%+3.39%+7.68%+10.67%+30.60%PSILAdvisorShares Psychedelics ETF+0.68%+0.25%+8.49%+38.53%+1,709.73%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHELXFranklin Genomic Advancements ETFN/AN/AN/AN/AN/AN/AN/AN/AIVRAInvesco Real Assets ESG ETFN/AN/AN/AN/AN/AN/AN/AN/AJCHIJPMorgan Active China ETFN/AN/AN/AN/AN/AN/AN/AN/APSILAdvisorShares Psychedelics ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHELXFranklin Genomic Advancements ETF 2.77Moderate Buy$29.27N/AIVRAInvesco Real Assets ESG ETF 2.73Moderate Buy$16.20N/AJCHIJPMorgan Active China ETF 2.57Moderate Buy$52.73N/APSILAdvisorShares Psychedelics ETF 3.05Buy$16.220.56% UpsideCurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHELXFranklin Genomic Advancements ETFN/AN/AN/AN/AN/AN/AIVRAInvesco Real Assets ESG ETFN/AN/AN/AN/AN/AN/AJCHIJPMorgan Active China ETFN/AN/AN/AN/AN/AN/APSILAdvisorShares Psychedelics ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHELXFranklin Genomic Advancements ETFN/AN/A26.71∞N/AN/AN/AN/AN/AIVRAInvesco Real Assets ESG ETFN/AN/A27.08∞N/AN/AN/AN/AN/AJCHIJPMorgan Active China ETFN/AN/A15.29∞N/AN/AN/AN/AN/APSILAdvisorShares Psychedelics ETFN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHELXFranklin Genomic Advancements ETFN/AN/AN/AN/AN/AIVRAInvesco Real Assets ESG ETF$0.623.83%N/AN/AN/AJCHIJPMorgan Active China ETF$0.921.74%N/AN/AN/APSILAdvisorShares Psychedelics ETF$0.332.05%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHELXFranklin Genomic Advancements ETFN/AIVRAInvesco Real Assets ESG ETFN/AJCHIJPMorgan Active China ETFN/APSILAdvisorShares Psychedelics ETFN/AInsider OwnershipCompanyInsider OwnershipHELXFranklin Genomic Advancements ETFN/AIVRAInvesco Real Assets ESG ETFN/AJCHIJPMorgan Active China ETFN/APSILAdvisorShares Psychedelics ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHELXFranklin Genomic Advancements ETFN/A400,000N/ANot OptionableIVRAInvesco Real Assets ESG ETFN/A810,000N/ANot OptionableJCHIJPMorgan Active China ETFN/A280,000N/ANot OptionablePSILAdvisorShares Psychedelics ETFN/A800,000N/ANot OptionableIVRA, HELX, JCHI, and PSIL HeadlinesRecent News About These CompaniesThis Psychedelics ETF Has Investors Going Crazy (In a Good Way)August 12 at 1:49 PM | etftrends.comE7 Best Psychedelic Stocks and ETFs to BuyJuly 18, 2025 | wtop.comW5 ETFs That Beat the Market in the First Half of 2025June 20, 2025 | zacks.com5 Sector ETFs That Have Outperformed the S&P 500 in Q1March 27, 2025 | zacks.com5 Best-Performing Sector ETFs Halfway Through Q1February 20, 2025 | zacks.comWhen the Price of (PSIL) Talks, People ListenFebruary 12, 2025 | news.stocktradersdaily.comN5 Best-Performing Sector ETFs of Volatile JanuaryFebruary 3, 2025 | zacks.com5 Best-Performing ETFs of JanuaryJanuary 31, 2025 | zacks.comUnder-the-Radar Opportunities in ETFsJanuary 30, 2025 | etftrends.comEETF Prime: Islam Shares 2025's Top Trends and ETFsJanuary 28, 2025 | etftrends.comE5 Best-Performing Sector ETFs of Q4January 2, 2025 | zacks.com(PSIL) Technical DataJanuary 1, 2025 | news.stocktradersdaily.comNTrend Tracker for (PSIL)December 20, 2024 | news.stocktradersdaily.comN(PSIL) Proactive StrategiesDecember 10, 2024 | news.stocktradersdaily.comNNo Trippin’: Trump Trade Pushes PSIL, VCAR HigherNovember 15, 2024 | finance.yahoo.com5 Best-Performing Sector ETFs Midway in Q4November 15, 2024 | zacks.com5 Best-Performing ETFs of OctoberNovember 1, 2024 | zacks.comDRUG Enhances Buzz for Psilocybin, Psychedelic ETFsOctober 18, 2024 | finance.yahoo.comTop and Flop ETFs of the First Nine MonthsSeptember 30, 2024 | zacks.com(PSIL) Pivots Trading Plans and Risk ControlsSeptember 27, 2024 | news.stocktradersdaily.comNIVRA, HELX, JCHI, and PSIL Company DescriptionsFranklin Genomic Advancements ETF BATS:HELX$29.16 +2.01 (+7.39%) Closing price 12:18 PM EasternExtended Trading$29.16 +0.00 (+0.00%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Franklin Genomic Advancements ETF (HELX) is an exchange-traded fund that is based on the Solactive Genomics index. The fund is an actively managed portfolio of global equity securities of companies relevant to genomic discovery. HELX was launched on Feb 25, 2020 and is managed by Franklin Templeton.Invesco Real Assets ESG ETF BATS:IVRA$16.26 +0.19 (+1.16%) Closing price 03:23 PM EasternExtended Trading$16.26 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Invesco Real Assets ESG ETF (IVRA) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed, non-transparent fund of North American real assets companies screened for both environmental, social, and governance (ESG) and fundamental factors. The fund utilizes the Fidelity non-transparent model. IVRA was launched on Dec 22, 2020 and is managed by Invesco.JPMorgan Active China ETF NYSEARCA:JCHI$52.47 -0.96 (-1.79%) Closing price 03:24 PM EasternExtended Trading$52.48 +0.00 (+0.00%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Active China ETF (JCHI) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed to hold a narrow portfolio of Chinese equities and equity-related securities that are fundamentally assessed for sustainable growth and disciplined capital management. The fund also considers ESG factors during the investment process JCHI was launched on Mar 15, 2023 and is managed by JPMorgan Chase.AdvisorShares Psychedelics ETF NYSEARCA:PSIL$16.20 -0.16 (-1.00%) Closing price 03:57 PM EasternExtended Trading$16.30 +0.10 (+0.64%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Cisco Systems: The Only AI Stock Income Investors Need to Own Gartner’s RSI Just Sank to 11: That’s a Setup You Can’t Ignore Brinker Serves Up Earnings Beat, Sidesteps Cost Pressures CAVA’s Honeymoon Ends With a 16% Stock Drop Rigetti Stock: A Long-Term Quantum Play Facing Short-Term Tests 5 Stocks Insiders Are Selling That Analysts Say Buy CoreWeave Pulls Back Into a Screaming Buy Amazon’s Bears Have Raised the White Flag—Get Excited Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access